4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001144204-10-057870
Options or other derivatives
- Director bought 1,707,500 shares at $512,250.00 ($874,666,875,000)
- Director acquired 341,498 shares (grant or award)
- Director returned 100,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
JONES DAVID B · Director
Table II: Derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2010-11-03 | Returned to the company : show line 1 in the form Common Stock Warrant | −50,000 | 50,000 | I | ||
| 2010-11-03 | Returned to the company : show line 2 in the form Common Stock Warrant | −50,000 | 50,000 | I | ||
| 2010-11-03 | Grant or award : show line 3 in the form Common Stock Warrant | +85,854 | 85,854 | I | ||
| 2010-11-03 | Grant or award : show line 4 in the form Common Stock Warrant | +85,854 | 85,854 | I | ||
| 2010-11-03 | Grant or award : show line 5 in the form Common Stock Warrant | +84,895 | 84,895 | I | ||
| 2010-11-03 | Grant or award : show line 6 in the form Common Stock Warrant | +84,895 | 84,895 | I | ||
| 2010-11-03 | Purchase : show line 7 in the form Call Option (Right to Buy) | +1,707,500 | $512,250.00 | $874,666,875,000 | 1,707,500 | I |
Loading xslF345X03/v200822_ex.xml…